Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
CoMentis |
---|---|
Information provided by: | CoMentis |
ClinicalTrials.gov Identifier: | NCT00414622 |
A Double Blind, Placebo-Controlled Randomized Study to Compare the Safety and Tolerability of GTS-21 (25 Mg TID, 50 Mg TID, 75 Mg TID and 150 Mg TID) When Administered Daily for 28 Days to Participants With Probable Alzheimer’s Disease
Condition | Intervention | Phase |
---|---|---|
Alzheimer Disease |
Drug: DMXB-A |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Double Blind, Placebo-Controlled Randomized Study to Compare the Safety and Tolerability of GTS-21 (25 Mg TID, 50 Mg TID, 75 Mg TID and 150 Mg TID) When Administered Daily for 28 Days to Participants With Probable Alzheimer’s Disease |
Estimated Enrollment: | 60 |
Study Start Date: | November 2006 |
Study Completion Date: | April 2007 |
A Double Blind, Placebo-Controlled Randomized Study to Compare the Safety and Tolerability of GTS-21 (25 Mg TID, 50 Mg TID, 75 Mg TID and 150 Mg TID) When Administered Daily for 28 Days to Participants With Probable Alzheimer’s Disease
Ages Eligible for Study: | 50 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | GTS21-201 |
Study First Received: | December 19, 2006 |
Last Updated: | April 18, 2007 |
ClinicalTrials.gov Identifier: | NCT00414622 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Alzheimer Probable Alzheimer disease |
3-(2,4-dimethoxybenzylidene)anabaseine Delirium, Dementia, Amnestic, Cognitive Disorders Mental Disorders Alzheimer Disease Central Nervous System Diseases |
Neurodegenerative Diseases Brain Diseases Dementia Cognition Disorders Delirium |
Delirium, Dementia, Amnestic, Cognitive Disorders Mental Disorders Nervous System Diseases Alzheimer Disease Central Nervous System Diseases |
Neurodegenerative Diseases Tauopathies Brain Diseases Dementia |